Vasile Staicu, Justinian-Andrei Tomescu, Ioan Calinescu
{"title":"Bioavailability of ursolic/oleanolic acid, with therapeutic potential in chronic diseases and cancer.","authors":"Vasile Staicu, Justinian-Andrei Tomescu, Ioan Calinescu","doi":"10.17219/acem/194013","DOIUrl":null,"url":null,"abstract":"<p><p>This study focused on describing the bioavailability of ursolic/oleanolic acids (UA/OA) and the methods to increase it, so that these 2 bioactive compounds can have therapeutic and preventive effects in chronic diseases and cancer. Ursolic/oleanolic acids are natural compounds that have been known since the 19th century. They are very widespread and offer special benefits for human health - especially that their high absorbability makes them suitable for use in therapeutic and preventive treatment. One of the important aspects of their bioavailability is related to their interaction with other bioactive compounds or drugs. In chronic diseases and cancer, UA/OA may affect the absorption of other nutrients and interact with bioactive compounds. By increasing the bioavailability of UA/OA with various technical processes, especially using nanocarriers and nanoparticles, these compounds can affect collagen production, contributing to maintaining skin elasticity and preventing the appearance of wrinkles. Today, UA/OA are frequently used to treat many conditions, ranging from chronic to metabolic.</p>","PeriodicalId":7306,"journal":{"name":"Advances in Clinical and Experimental Medicine","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Clinical and Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17219/acem/194013","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
This study focused on describing the bioavailability of ursolic/oleanolic acids (UA/OA) and the methods to increase it, so that these 2 bioactive compounds can have therapeutic and preventive effects in chronic diseases and cancer. Ursolic/oleanolic acids are natural compounds that have been known since the 19th century. They are very widespread and offer special benefits for human health - especially that their high absorbability makes them suitable for use in therapeutic and preventive treatment. One of the important aspects of their bioavailability is related to their interaction with other bioactive compounds or drugs. In chronic diseases and cancer, UA/OA may affect the absorption of other nutrients and interact with bioactive compounds. By increasing the bioavailability of UA/OA with various technical processes, especially using nanocarriers and nanoparticles, these compounds can affect collagen production, contributing to maintaining skin elasticity and preventing the appearance of wrinkles. Today, UA/OA are frequently used to treat many conditions, ranging from chronic to metabolic.
期刊介绍：
Advances in Clinical and Experimental Medicine has been published by the Wroclaw Medical University since 1992. Establishing the medical journal was the idea of Prof. Bogumił Halawa, Chair of the Department of Cardiology, and was fully supported by the Rector of Wroclaw Medical University, Prof. Zbigniew Knapik. Prof. Halawa was also the first editor-in-chief, between 1992-1997. The journal, then entitled "Postępy Medycyny Klinicznej i Doświadczalnej", appeared quarterly.
Prof. Leszek Paradowski was editor-in-chief from 1997-1999. In 1998 he initiated alterations in the profile and cover design of the journal which were accepted by the Editorial Board. The title was changed to Advances in Clinical and Experimental Medicine. Articles in English were welcomed. A number of outstanding representatives of medical science from Poland and abroad were invited to participate in the newly established International Editorial Staff.
Prof. Antonina Harłozińska-Szmyrka was editor-in-chief in years 2000-2005, in years 2006-2007 once again prof. Leszek Paradowski and prof. Maria Podolak-Dawidziak was editor-in-chief in years 2008-2016. Since 2017 the editor-in chief is prof. Maciej Bagłaj.
Since July 2005, original papers have been published only in English. Case reports are no longer accepted. The manuscripts are reviewed by two independent reviewers and a statistical reviewer, and English texts are proofread by a native speaker.
The journal has been indexed in several databases: Scopus, Ulrich’sTM International Periodicals Directory, Index Copernicus and since 2007 in Thomson Reuters databases: Science Citation Index Expanded i Journal Citation Reports/Science Edition.
In 2010 the journal obtained Impact Factor which is now 1.179 pts. Articles published in the journal are worth 15 points among Polish journals according to the Polish Committee for Scientific Research and 169.43 points according to the Index Copernicus.
Since November 7, 2012, Advances in Clinical and Experimental Medicine has been indexed and included in National Library of Medicine’s MEDLINE database. English abstracts printed in the journal are included and searchable using PubMed http://www.ncbi.nlm.nih.gov/pubmed.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
